norml08 - Page 44



Page 44 Previous , Next , Original Image
Return to Index

 '
 marijuana_s bioavaiiability, metabolic pathways and
 pharmacokinetics is inadequate. Studies in humans are too
 small and too few° Sophisticated epidemioiogical studies of
 marijuana use in large populations are required, similar to
 those done for tobacco use. Far too many questions remain
 unknown for experts fairly and responsibly to conclude
 marijuana is safe for any use.
 Third, there are no adequate_ well-controlled
 scientific studies proving marijuana is effective for
 anything.
 Fourth, marijuana is not accepted for medical use in
 treatment by even a respectable minority_ much less a
 consensus_ of experts trained to evaluate drugs. The FDA's
 expert drug evaluators have rejected marijuana for medice!
 use. No NDA has been approved by FDA for marijuana. The
 testimony of nationally recognized experts overwhelmingly
 rejects marijuana as medicines compared to the
 scientifically empty testimony of the psychiatrists, a
 wellness counselor and general practitioners presented by
 NORML.
 Fifths given my conclusions on points one, two and
 threes it follows that the published scientific evidence is
 not adequate to permit experts to fairly and responsibly
 conclude that marijuana is safe and effective for use in
 humans.
 44




Previous , Next , Return to Index